Dr Priya Sriskandarajah achieved her medical degree at Kings College London in 2007. She then embarked on haematology training as a National Institute for Health and Care Research Academic Clinical Fellow in South West London with posts at the Royal Marsden Hospital as well as Epsom and St Helier. In 2019, she obtained her PhD at the Institute of Cancer Research, examining molecular targets in RAS-mutant multiple myeloma. During her PhD, she was also a Clinical Fellow at the Institute of Cancer Research involved in Phase I trials as well as a sub-investigator on Phase III studies.
In 2020, she transferred to Guy’s and St Thomas’ trust as a Clinical Fellow, where she screened and managed patients with Systemic Mastocytosis (SM) in Phase III clinical trials. During this time she co-led a project examining the implications of the COVID-19 vaccine in patients diagnosed with Systemic Mastocytosis which was later published. She also presented abstracts at both national and international level examining prognostic factors in SM patients as well as the impact of allogeneic stem cell transplant.
Currently, Dr Sriskandarajah is working as a locum consultant within the Myeloproliferative Neoplasms (MPN) and General Haematology services at Guy’s and St Thomas’ Hospital. During this time she has led a teaching programme focusing on laboratory diagnostics for haematology trainees, as well as co-led recent audit projects with junior doctors which have been accepted for presentation at a national conference. She has also recently been a co-author on the upcoming edition of ‘Crash Course in Haematology and Immunology’ textbook aimed at medical students.
